HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dr. Reddy's Laboratories Ltd.

www.drreddys.com

Latest From Dr. Reddy's Laboratories Ltd.

Amneal’s Amicar Rival Gets CGT Exclusivity

After receiving a CGT designation by the FDA for its generic version of Amicar, Amneal gets 180 days of exclusivity.

Generic Drugs Regulation

France Adds Seretide, Lyrica and Xarelto Rivals To Repertoire

Generic versions of Seretide Diskus, Lyrica and Xarelto are among the latest additions to France’s repertoire of generic equivalents.

Generic Drugs Regulation

Lupin Rationalizes Japan Operations, Sheds Injectables Business

Lupin sells Japanese injectables business, eight years after it made an acquisition in that segment there. The Indian firm now plans to concentrate on building a hybrid pharma model in the country.

Japan Deals

Lupin Rationalizes Japan Operations, Sheds Injectables Business

Lupin sells Japanese injectables business, eight years after it made an acquisition in that segment there. The Indian firm now plans to concentrate on building a hybrid pharma model in the country.

Japan Deals
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register